利用马拉韦罗治疗经验临床试验计划登记患者的筛选样本,回顾性分析得出结论:在使用HIVV3基因定型分析和Trofile(TM)(原先在临床试验计划中使用的重组细胞表型试验)进行检测的患者之间 ,艾滋病毒水平的变化以及获得无法检测的病毒载量的患者百分比很接近,表明两种检测方法在确定经马拉韦罗( maraviroc)治疗后有起色的患者方面...
© Linguee 词典, 2024 ▾ 外部资源(未审查的) What depositors want to know the most is certainlyhow much interesttheywill earn from banks. legco.gov.hk legco.gov.hk 存戶最 想 知道的,當然 是可從 銀行 收取多少利息,至於銀行服務是否良 ...
Watch the Latest from AppleInsider TV iPhone sales in line with expectations (Product)Red iPhone 7 recognizes 10 year of partnership with the program fighting AIDS and HIV. Customer response has been "wonderful," Cook said. iPhone ASP was $655, up from $642 in the same period a year ago...
In the context of HIV co-infection, rapid point-of-care tests gain importance in both the developing and developed countries. Moreover, in the ... S Shivkumar,Y Jafari,G Lambert,... - 《Sexually Transmitted Infections》 被引量: 0发表: 2011年 Personalization Method for Tourist Point of ...
(as seen notably in the Millennium Declaration of the United Nations General Assembly, especially Chapter VII), the Abuja Summit on HIV/AIDS, Tuberculosis and other Infectious Diseases and the creation of a Global Fund to fight HIV/AIDS, and also by Africans’ determination to build the unity ...
the Conference on Disarmament [...] daccess-ods.un.org daccess-ods.un.org 大会第六十六届会议邀请裁军谈判会议在其 2012 年会议期间尽早在这个议 程项目下设立一个工作组;并且敦促从事外层空间活动的国家以及有意从事这种 活动的国家,将有关这个问题的任何双边和多边谈判的进展情况随时通知裁军谈 判会议(第...
spark名— 火花名 · 思邦名 · 闪光名 · 朝气名 · (Spark)人名 斯帕克专名 spark— 火花 · 火星 · 闪 · 触发 spark(sb./sth.)动— 鼓舞...动 · 发火花动 · 发动...动 · 求婚动 · 闪烁动 · 向 某人求婚动 renewed过-分— ...
through the TreatyofTlatelolco about 40 years ago, welcome the convening of the Second Conference of States Parties and Signatories to Treaties that Establish Nuclear-Weapon-FreeZonesandMongolia to consider ways and means to enhance consultations among States parties and signatories, treaty agencies and...
combating HIV/AIDS. unesdoc.unesco.org unesdoc.unesco.org (e) 认为各级政府和各政府部门之间的合作是成功的,县村镇级官员都表示坚决同艾滋病 毒/艾滋病作斗争。 unesdoc.unesco.org unesdoc.unesco.org This is an areaofgreat interesttothe tobacco ...
Gilead Sciences gained more than 9 per cent after it reported a late-stage trial showed the company’s twice-a-year injectable to prevent HIV in women was more effective than its once-a-day Truvada pill. Share $Risers and fallers in North America on X (opens in a new window) Share $...